Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunotherapy targets in critical care

H J Mann, K Vance-Bryan

    Critical Care Nursing Clinics of North America
    |June 1, 1993
    PubMed
    Summary

    New immunotherapies, including colony stimulating factors and immunoglobulins, show promise for improving outcomes in critically ill patients with sepsis. These treatments target the immune system to reduce illness and death.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Changes in vasopressin use and outcomes in surgical intensive care unit patients with septic shock.

    Chirurgia (Bucharest, Romania : 1990)·2009
    Same author

    Pharmacokinetics of tiletamine and zolazepam (Telazol) in anesthetized pigs.

    Journal of veterinary pharmacology and therapeutics·2006
    Same author

    Pharmacy technology of the ICU. Today and tomorrow.

    Critical care clinics·2000
    Same author

    Time to patient discontinuation of antihypertensive drugs in different classes.

    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2000
    Same author

    In favor of Coumadin over generic warfarin.

    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·1998
    Same author

    Effect of pharmacokinetic sampling methods on aminoglycoside dosing in critically ill surgery patients.

    Pharmacotherapy·1998

    Area of Science:

    • Immunology
    • Critical Care Medicine
    • Pharmacology

    Background:

    • Understanding of the immune system and injury response has advanced.
    • Sepsis treatment is evolving with new therapeutic strategies.
    • Adjunctive immunotherapy is a promising area for critically ill patients.

    Purpose of the Study:

    • To review the scientific basis for using adjunctive immunotherapy in critically ill patients.
    • To highlight investigational immunotherapeutic agents for sepsis.
    • To discuss the potential impact on morbidity and mortality.

    Main Methods:

    • Literature review of current research on immunotherapy for critical illness.
    • Analysis of investigational agents targeting immune pathways.
    • Synthesis of evidence supporting immunotherapeutic interventions.

    Main Results:

    • Significant data supports immunotherapy's role in improving sepsis outcomes.
    • Investigational agents include colony stimulating factors, immunoglobulins, anticytokines, and opioid antagonists.
    • These therapies aim to modulate the immune response in sepsis.

    Conclusions:

    • Adjunctive immunotherapy offers a potential strategy to improve outcomes in critically ill patients with sepsis.
    • Further research into these agents is warranted.
    • Targeting the immune system is key to advancing critical care for sepsis.

    Related Experiment Videos